NEW YORK (Reuters Health) - A study of Northern California children finds that diagnoses of the digestive disease ulcerative colitis increased nearly three-fold between 1996 and 2006 -- for reasons ...
MedPage Today on MSN
Upadacitinib Shows 1-Year Benefit in Pediatric IBD
Single-center study finds durable, steroid-free remission, especially in ulcerative coliti ...
The FDA has approved Remicade from Janssen Biotech to treat moderately to severely active ulcerative colitis in children over age 6 who responded inadequately to conventional therapy, according to an ...
Researchers examined treatment and prognosis for severe-onset ulcerative colitis in children. Children with severe-onset ulcerative colitis may require treatment with biologic agents. Severe-onset ...
On Tuesday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s (NYSE:JNJ) Simponi (golimumab) for children with moderately to severely active ulcerative colitis (UC) who weigh at ...
Treatment for microscopic colitis usually involves medications to reduce inflammation and immune activity in the colon and lifestyle changes to reduce symptoms. Microscopic colitis, a chronic type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results